Terms: = Breast cancer AND SEPT6, RP5-876A24_2, 23157, ENSG00000125354, Q14141, SEP2, MGC16619, KIAA0128, MGC20339 AND Treatment
49282 results:
1. The Experience of cancer-Related Cognitive Impairment Across Common cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.
Fu Y; Zhou J; Li J
PLoS One; 2024; 19(5):e0303669. PubMed ID: 38820391
[TBL] [Abstract] [Full Text] [Related]
3. Exposure to Low-Frequency Radiation Changes the Expression of Nestin, VEGF, BCRP and Apoptosis Markers During Glioma treatment Strategy: An
Amirinejad M; Eftekhar-Vaghefi SH; Nematollahi Mahani SN; Salari M; Yahyapour R; Ahmadi-Zeidabadi M
Curr Radiopharm; 2024; 17(1):55-67. PubMed ID: 38817005
[TBL] [Abstract] [Full Text] [Related]
4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity.
Houlahan KE; Khan A; Greenwald NF; Vivas CS; West RB; Angelo M; Curtis C
Science; 2024 May; 384(6699):eadh8697. PubMed ID: 38815010
[TBL] [Abstract] [Full Text] [Related]
5. [Anti-tumor mechanism of total saponins of Paridis Rhizoma on inducing ferroptosis of breast cancer MCF-7 cells].
Zhang YB; Zhang HZ; Ruan YD; Zhang YQ; Zhang PZ; Yao AN; Li SM; Xu XH; Ni J; Dong XX
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2385-2392. PubMed ID: 38812139
[TBL] [Abstract] [Full Text] [Related]
6. Perceived barriers and factors influencing uptake of breast cancer screening among women: a population-based cross-sectional study.
Joho AA; Mdoe MB; Masoi TJ; Yahaya JJ
Sci Rep; 2024 May; 14(1):12291. PubMed ID: 38811672
[TBL] [Abstract] [Full Text] [Related]
7. The gut microbiota in persistent post-operative pain following breast cancer surgery.
Masaud K; Collins JM; Rubio RC; Corrigan M; Cotter PD; O'Brien N; Bluett R; Jimenez CK; O'Mahony SM; Shorten GD
Sci Rep; 2024 May; 14(1):12401. PubMed ID: 38811609
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Genes Hub Associated with Triple-Negative breast cancer and Cannabidiol Analogs Potential Inhibitory Agents: An In-silico Study.
Contreras-Puentes N; Alviz-Amador A; Zabaleta-Guzman JA; Pineda Aleman R; Tarón Dunoyer A
Asian Pac J Cancer Prev; 2024 May; 25(5):1649-1661. PubMed ID: 38809637
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of Potential Target Genes of Borneol in Increasing Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant breast cancer: Bioinformatics and In Vitro Studies.
Lestari IA; Putra IMR; Fatimah N; Ujiantari NSO; Putri DDP; Hermawan A
Asian Pac J Cancer Prev; 2024 May; 25(5):1623-1634. PubMed ID: 38809634
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study.
Dai S; Zhang Y; Tan X; Luo F; Yan X
Cancer Med; 2024 Jun; 13(11):e7256. PubMed ID: 38808952
[TBL] [Abstract] [Full Text] [Related]
11. Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis.
Ciapponi A; Bardach A; Colaci C; Rodríguez Cairoli F; Argento F; Korbenfeld E; García Martí S
Rev Peru Med Exp Salud Publica; 2024 May; 41(1):7-18. PubMed ID: 38808848
[TBL] [Abstract] [Full Text] [Related]
12. mitoBK
Bischof H; Maier S; Koprowski P; Kulawiak B; Burgstaller S; Jasińska J; Serafimov K; Zochowska M; Gross D; Schroth W; Matt L; Juarez Lopez DA; Zhang Y; Bonzheim I; Büttner FA; Fend F; Schwab M; Birkenfeld AL; Malli R; Lämmerhofer M; Bednarczyk P; Szewczyk A; Lukowski R
Elife; 2024 May; 12():. PubMed ID: 38808578
[TBL] [Abstract] [Full Text] [Related]
13. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
[TBL] [Abstract] [Full Text] [Related]
14. Oocyte collection and outcome following oncologic treatment: a retrospective multicentre study.
Fernández-González MJ; Borgmann-Staudt A; Llagostera CG; Ceballos-Garcia E; Gebauer J; Jantke A; Barnbrock A; Kentenich H; Klco-Brosius S; Lotz L; Balcerek M
Support Care Cancer; 2024 May; 32(6):390. PubMed ID: 38806697
[TBL] [Abstract] [Full Text] [Related]
15. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
[TBL] [Abstract] [Full Text] [Related]
16. The Remarkable Anti-breast cancer Efficacy and Anti-Metastasis by Multifunctional Nanoparticles Co-Loading Squamocin, R848 and IR 780.
Wang X; Liu X; Guo Y; Gong T; Lu W; Han M; Guo Y; Wang X
Int J Nanomedicine; 2024; 19():4679-4699. PubMed ID: 38803997
[TBL] [Abstract] [Full Text] [Related]
17. Experiences and perceived benefits of remotely delivered dance/movement therapy for adult cancer patients: a multi-method program evaluation.
Bryl K; Whitley J; Lopez-Nieves I; Liou K; Chimonas S; Tortora S; Mao JJ
Support Care Cancer; 2024 May; 32(6):388. PubMed ID: 38802666
[TBL] [Abstract] [Full Text] [Related]
18. A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms.
Rahman MM; Wu H; Tollefsbol TO
Sci Rep; 2024 May; 14(1):12091. PubMed ID: 38802425
[TBL] [Abstract] [Full Text] [Related]
19. Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.
Dowling GP; Daly GR; Hegarty A; Hembrecht S; Bracken A; Toomey S; Hennessy BT; Hill ADK
Br J Surg; 2024 May; 111(5):. PubMed ID: 38801441
[TBL] [Abstract] [Full Text] [Related]
20. Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity.
Püsküllüoğlu M; Grela-Wojewoda A; Ambicka A; Pacholczak-Madej R; Pietruszka A; Mucha-Małecka A; Rudzińska A; Ziobro M; Ryś J; Mituś JW
Front Endocrinol (Lausanne); 2024; 15():1217495. PubMed ID: 38800480
[TBL] [Abstract] [Full Text] [Related]
[Next]
